Status:
COMPLETED
Vitamin D Testing and Treatment for COVID 19
Lead Sponsor:
Arizona State University
Collaborating Sponsors:
Southwest College of Naturopathic Medicine
Conditions:
Covid 19
Vitamin D Deficiency
Eligibility:
All Genders
18+ years
Phase:
PHASE1
Brief Summary
This study will measure vitamin D levels in adults with COVID 19. Participants with low levels of vitamin D will be entered into an open label trial of supplementation with vitamin D.
Detailed Description
Protocol for Part 1: * A single blood draw at SCNM to measure levels of vitamin D and other nutrients, comprehensive metabolic panel, and complete blood count with differential * Completing a medical...
Eligibility Criteria
Inclusion
- Inclusion Criteria for Part 1 (testing):
- Adult age 18 or older
- Previous positive test result for COVID 19
- Able to communicate clearly in English Exclusion Criteria for Part 1 (testing): none
- Inclusion Criteria for Part 2 (Vitamin D supplementation)
- Participation in Part 1
- Vitamin D level below 30 ng/ml
- No abnormalities on the comprehensive metabolic panel that are clinically significant to increasing the risk of an adverse reaction to vitamin D supplementation
- Exclusion Criteria for Part 2 (Vitamin D supplementation):
- Liver impairment
- Clinical opinion of study physician that vitamin D supplementation could be harmful to the participant.
- Pregnancy
- No symptoms for 2 weeks after positive COVID 19 test
- Recovered from symptoms
Exclusion
Key Trial Info
Start Date :
May 19 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 30 2020
Estimated Enrollment :
41 Patients enrolled
Trial Details
Trial ID
NCT04407286
Start Date
May 19 2020
End Date
November 30 2020
Last Update
December 30 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Arizona State University
Tempe, Arizona, United States, 85287